SciELO - Scientific Electronic Library Online

 
vol.33 issue2Effect of two processing techniques used to manufacture lithium disilicate ceramics on the degree of conversion and microshear bond strength of resin cementProspective clinical study of transverse development with orthodontics with self-ligating brackets author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Acta Odontológica Latinoamericana

Print version ISSN 0326-4815On-line version ISSN 1852-4834

Acta odontol. latinoam. vol.33 no.2 Buenos Aires Sept. 2020  Epub Sep 01, 2020

 

ORIGINAL ARTICLE

Enzyme production by Candida albicans and Candida dubliniensis in periodontal HIV-positive patients receiving and not receiving antiretroviral therapy

Producción enzimática de Candida albicans y Candida dubliniensis de pacientes con periodontitis VIH+ con y sin tratamiento antirretroviral

 Verónica A. Dubois1  5 

María I González1  5 

María E Martínez1  5 

Laura Fedelli1  5 

Sabrina Lamas1 

Luciana R. D Eramo3  4  5 

Aldo F Squassi3  4  5 

Gabriel A Sánchez2  3 

Pablo Salgado1  4  5 

Laura A Gliosca1  5 

Susana L Molgatini1  5 

1Universidad de Buenos Aires. Facultad de Odontología. Hospital Odontológico Universitario. Cátedra de Microbiología y Parasitología, Buenos Aires, Argentina

2Universidad de Buenos Aires. Facultad de Odontología. Hospital Odontológico Universitario Cátedra de Biofísica y Bioestadística, Buenos Aires, Argentina

3Universidad de Buenos Aires, Facultad de Odontología, Clínica para La Atención de Pacientes de Alto Riesgo médico, Buenos Aires, Argentina

4Universidad de Buenos Aires, Facultad de Odontología, Cátedra de Odontología Preventiva y Comunitaria, Buenos Aires, Argentina

5Universidad de Buenos Aires, Instituto de Investigaciones en Salud Pública, Buenos Aires, Argentina

ABSTRACT

Candida dubliniensis (Cd) and Candida albicans (Ca) are the most frequently isolated yeasts in HIV+ patients. Some of the enzymes produced by these yeasts are considered virulence factors since they contribute to pathogenicity of Candida spp. The aim of the present study was to compare production of enzymes such as phospholipase (Ph), proteinase (P), and hemolysin (H) by Cd and Ca strains isolated from periodontal HIV-positive patients receiving and not receiving highly active antiretroviral therapy (HAART). Subgingival biofilm samples were obtained using paper points, and a sample of oral mucosa was taken using a swab. Phenotypic and molecular methods were used to isolate 39 strains of Candida, including 25 strains of Cd and 14 strains of Ca, obtained from 33 periodontal pocket samples and 6 oral mucosa samples collected from 15 HIV+ patients (8 receiving and 7 not receiving HAART). Malt egg-yolk agar, albumin agar and blood agar were used to evaluate pH, P and H production respectively. The strains were inoculated in duplicate and incubated at 37 ºC. Colony and halo diameters were measured. A greater proportion of Ca was observed in patients not receiving HAART, and a higher proportion of Cd was observed in those under HAART, Chi2 p< 0.001. Phospholipase production was observed in 92.9% percent of isolated Ca strains but in none of the isolated Cd strains. Proteinase production was high in Ca and Cd strains isolated from patients not receiving HAART. Hemolysin production was observed in all the studied strains, though it was significantly higher (p=0.04) in Ca and Cd strains isolated from patients not receiving HAART. To sum up, the proportion of Candida dubliniensis strains was highest in the subgingival biofilm of patients receiving HAART, and Cd strains were found to express fewer virulence factors than Ca strains.

Keywords: Candida albicans; HIV; Periodontitis; Antiretroviral therapy

RESUMEN

Las levaduras más aisladas en pacientes VIH+ son Candida dubliniensis (Cd) y Candida albicans (Ca). Algunas de sus enzimas constituyen factores de virulencia ya que favorecen la diseminación tisular. El objetivo fue comparar la producción de enzimas como fosfolipasa (F), proteinasa (P) y hemolisina (H) en cepas de Cd y Ca aisladas de pacientes VIH+ tratados y no tratados con antirretrovirales (TARGA). Se realizó la toma del biofilm de placa subgingival con conos de papel y la muestra de la mucosa bucal con hisopo. Se aislaron y tipificaron por métodos fenotípicos y moleculares 39 cepas: 25 de Cd y 14 Ca, obtenidas 33 de bolsas periodontales y 6 de mucosa bucal de 15 pacientes VIH+ (8 con y 7 sin tratamiento). Se utilizó agar malta con yema de huevo, agar albúmina y agar sangre para demostrar la producción de F, P y H, respectivamente. Se inocularon por duplicado e incubaron a 37°C. Se midieron los diámetros de las colonias y los de hidrólisis alrededor de las mismas. Se observó mayor proporción de Ca en los pacientes sin tratamiento y mayor proporción de Cd en los con tratamiento; Chi2 p< 0.001. El 92,9% de las Ca estudiadas, fueron productoras de fosfolipasa. En tanto que ninguna Cd produjo la enzima. En cuanto a la producción de proteinasa se observa una alta producción tanto en las cepas de Ca, como en las Cd aisladas en los pacientes no tratados. Todas las cepas estudiadas produjeron hemolisina, observándose una diferencia estadísticamente significativa (p=0,04) en ambas especies a favor de la alta producción de la enzima en las cepas obtenidas de pacientes no tratados. Podemos concluir que en el biofilm subgingival, en los pacientes bajo TARGA, se aíslan mayor proporción de Candida dubliniensis las cuales expresan menos factores de virulencia.

Palabras clave: Candida albicans; VIH; Periodontitis; Terapia antiretroviral

INTRODUCTION

Colonization by Candida species begins within the first few days of life. Although the oral mucosa is a reservoir, Candida spp. are also present in the biofilm of periodontal pockets of patients with periodontitis, endodontic infection and periimplantitis1.

In 30 to 50% of subjects, Candida spp. colonize the oral cavity and the digestive tract, and are more frequent in lactating infants, elderly subjects who use a dental prosthesis, people who have received antibiotic treatment or chemotherapy, patients with poorly controlled diabetes, and hospitalized and immunosuppressed patients2.

Asymptomatic colonization of the oral mucosa is more prevalent among HIV+ subjects and considered an important predisposing factor for candidiasis.

The advent of highly active antiretroviral treatment (HAART) has markedly improved the immune system of HIV+ patients, substantially decreasing the incidence of opportunistic infections3.

The most frequently isolated yeasts form the oral cavity of HIV+ patients are Candida albicans and Candida dubliniensis. These species share a number of phenotypic features, such as the formation of green colonies in chromogenic media and the ability to produce chlamydospores and pseudofilaments4" 7. The virulence factors of these yeasts include phenotypic change, dimorphism, adherence capacity and secretion of lytic enzymes such as phospholipase, proteinase and hemolysin, among others8,9.

Production of these enzymes can therefore be an important determining factor of the potential of these microorganisms to produce invasive infection in certain groups of individuals, as is the case of immunocompromised patients10.

The aim of the present study was to describe and compare enzyme production by commensal strains of Candida albicans and Candida dubliniensis obtained from different oral ecological niches in periodontal HIV+ patients, receiving and not receiving highly active antiretroviral therapy (HAART).

MATERIALS AND METHODS

The study population comprised adults living with HIV/AIDS residents in the Buenos Aires City, who attend dental care services. The sample included 15 HIV patients (8 receiving and 7 not receiving HAART) seen at the High-Risk Patients Oral Care Unit (CLAPAR I), School of Dentistry, University of Buenos Aires, who underwent oral examination after they had voluntarily signed an informed consent form. The study was approved by the Ethics Committee of the School of Dentistry, University of Buenos Aires (Resolution 21/11/2012-33).

Patients aged 18 to 60 years, diagnosed with HIV infection (confirmed by 2 positive ELISA tests and 1 Western Blot or similar), with a minimum 6 teeth and one site per quadrant with a probing depth equal to or higher than 5mm, attachment loss, and positive bleeding on probing, were included in the study. Only HAART patients who had remained on the same regimen the whole year prior to study enrolment were included.

Patients with systemic disease unrelated to HIV infection prior to or presenting during the study, receiving antibiotic/antifungal and/or oral-antiseptic treatment within 3 months prior to microbiological testing, showing mucosal candidiasis lesions, receiving oral care at other private or public oral health care services, and/or who smoked were excluded from the study.

Under adequate lighting conditions and using standardized instruments (a Marqis color-coded probe and a dental mirror), a calibrated researcher assessed the following clinical parameters of periodontal disease at 6 different sites per tooth (3 on the buccal aspect and 3 on the palatal or lingual aspect): presence of biofilm, probing depth (PD), clinical attachment level (CAL) and bleeding on probing (BP).

The patients were then instructed to rinse their mouth with distilled water. The site showing the worst periodontal parameters in each quadrant was identified. Following removal of the supragingival plaque using a curette and tooth isolation with cotton rolls, subgingival biofilm samples were collected using 4 paper points placed one at a time into the depth of the pocket for 20 seconds. The obtained samples were placed in reduced transport fluid (RTF) medium. A sample of oral mucosa was obtained using a swab, which was placed in a tube containing RTF medium.

All the samples were submitted to the microbiology laboratory for processing.

Microbiological Procedures

The samples were homogenized by shaking in a vortex mixer; 50 pl of each suspension were seeded in CHROMagar Candida® for presumptive identification of the species7.

C. albicans and C. dubliniensis were distinguished by using conventional phenotypic methods5,6: cultures on milk-tween 80 agar for detection of germ-tubes, pseudofilaments, and chlamydospores11, cultures on Sabouraud Dextrose Agar (SDA) incubated at 45 °C12, and cultures on Staib agar for production of chlamydospores13.

Molecular identification

Genomic DNA was extracted from pure and fresh 24-h cultures in SDA. Cell lysis was reached by heating at 100 °C and centrifuging at 16000g.

Two species-specific primers derived from the internally transcribed spacer (ITS) region (comprising the ITS1, 5.8s rRNA and ITS2 regions) as described by Asadzadeh et al.14 were used. Amplification reactions were performed by real time PCR (qPCR) using 2X SYBR Green Supermix in a 10 pl final volume, 10 pM of each primer, and 2 pl of genomic DNA, in a thermal cycler (CFX96 C1000 Touch, BioRad, Hercules, CA, USA). PCR cycling conditions were as follows: denaturation at 95 °C for 5 minutes, followed by 39 amplification cycles at 95 °C for 15 seconds, 60 °C for 30 seconds, 65 °C for 5 minutes, and 95 °C for 5 minutes.

The amplification process was evaluated using MCA (melting curve analysis) according to Asadzadeh et al. 14.

Detection of enzyme activity

All the isolated strains were seeded in SDA and incubated at 37 °C for 18h. The cultures were used to prepare suspensions adjusted to 1 McFarland standard (1 x 106 CFU/ml).

Phospholipase, proteinase and hemolysin production was detected using malt agar supplemented with sterile egg yolk emulsion (2%)8, bovine serum albumin agar8, and SDA with sterile sheep blood (7%)15, respectively.

Sterile paper discs were placed on the surface of each dish containing the corresponding medium, inoculated with 10 pl of the suspension, and incubated under aerobic conditions at 37 °C. The assays were performed in duplicate.

Phospholipase production was assessed at 72 h and was considered positive when a zone of precipitation was observed around the colony.

The precipitation zone (Pz) value was calculated as the ratio of the diameter of the colony to the total diameter of the colony plus the precipitation zone16. Enzyme production was classified according to the Pz value as follows: Pz value = 0.35 - 0.5 (high producers), Pz value = 0.51 - 0.74 (moderate producers); Pz value = 0.75 -0.9 (low producers); and Pz value = 1 (negative)17. Hemolytic halos were measured, and the enzymatic activity Pz value was calculated according to the ranges defined above.

Proteinase production was determined seven days post-incubation; the dishes were stained with a 0.6% amido black solution and destained with acetic acid8. The presence of a hydrolysis zone around the colony showed positive proteinase activity.

Candida albicans ATCC 10231 was used as positive control for the production of all three enzymes, Candida glabrata ATCC 90030 was used as negative control for phospholipase, and Candida parapsilopsis ATCC 22019 was used as negative control for hemolysin and proteinase.

Statistical Analysis

Categorical variables were analyzed as frequencies and percentages using 95% confidence intervals, and comparisons were established using Chi square test with Yates' continuity correction. In all cases, statistical tests for independent samples were used and level of statistical significance was less than 5% to reject the null hypothesis.

All statistical analyses were performed using SPSS software version 26, MS Excel 2016, Epidat 4.0.

RESULTS

As shown by the clinical records, 7 (46.7%) of the 15 studied patients were women and 8 (53.3%) were men, and all 15 patients contracted the virus by sexual transmission.

Mean age of the patients was 41 years (SD±10 years) and age range was 28 to 58 years. Analysis of the population according to age group showed that 20.0% were below the age of 30 years, 33.0% were between the age of 30 and 40 years, and 47.0% were over the age of 40 years.

Forty-seven percent of patients had been diagnosed with HIV within 10 years prior to the study, and 53.0% had been diagnosed more than 10 years before enrolment in the study. Eight patients (53.0%) were receiving HAART and 7 (47.0%) were not receiving HAART at the time of the study; 50% of patients receiving HAART had been under treatment for more than 10 years.

A total 75 samples, including 60 samples (80.0%) of subgingival biofilm and 15 samples (20.0%) of oral mucosa, were obtained from 15 patients. A total 39 strains of Candida genus were isolated: 14 (35.9%) Candida albicans and 25 (64.1%) Candida dubliniensis strains. Distribution according to species and localization is shown in Table 1.

Table 1 Frequency and percentage distribution of Candida spp. according to localization. 

Both species were isolated from the same periodontal site in two patients, one receiving and one not receiving HAART.

No statistically significant differences in the distribution of Candida species or localization were observed; chi square test p=0.887.

Analysis of the isolated species according to presence or absence of treatment showed 3 C. albicans (13%) and 20 C. dubliniensis (87%) strains in the 8 patients receiving HAART, and 11 C. albicans (68.8%) and 5 C. dubliniensis (31.2%) strains in the 7 patients not receiving HAART (Fig 1).

Fig. 1 Percentage distribution of Candida spp. according to presence/absence of HAART. 

A greater proportion of Candida albicans was observed in patients not receiving HAART, and a higher proportion of Candida dubliniensis was observed in patients under HAART; Chi square test p< 0.001.

In view of the distribution of phospholipase and proteinase production, the statistical analysis was performed considering positive or negative production (presence /absence) and Pz values were not considered.

Phospholipase production was observed in 13 (92.9%) of the 14 Candida albicans strains, 11 of which were isolated from patients not receiving HAART and 2 from patients under HAART (Table 2). However, no phospholipase production was observed in any of the Candida dubliniensis strains from either group.

Table 2 Frequency and percentage distribution of phospholipase production by Candida albicans strains isolated from patients receiving and not receiving HAART. 

Proteinase production was higher in both Candida albicans and Candida dubliniensis strains isolated from patients not receiving HAART; Chi square test, p< 0,001 (Fig. 2 and Table 3).

Fig. 2 Percentage distribution of proteinase production by Candida albicans and Candida dubliniensis strains isolated from patients receiving and not receiving HAART. 

Table 3 Frequency and percentage distribution of proteinase production by Candida spp. isolated from patients receiving and not receiving HAART. 

As regards hemolysin production, all the studied strains were found to produce the enzyme, and production was significantly higher (p=0.04) both in Ca and in Cd strains isolated from patients not receiving HAART (Fig. 3 and Table 4).

Fig. 3 Percentage distribution of hemolysin production by Candida albicans and Candida dubliniensis strains isolated from patients receiving and not receiving HAART. 

Table 4 Frequency and percentage distribution of hemolysin production by Candida spp. isolated from patients receiving and not 

DISCUSSION

The distribution of age, sex, and mode of acquisition of HIV infection was similar in both study groups of patients. Of note, all the studied yeast strains were isolated from oral mucosa and periodontal pockets of patients with no clinical manifestation of candidiasis.

In the present study, a larger number of strains of both Candida albicans and Candida dubliniensis was isolated from subgingival biofilm (Table 1). Although the role of yeasts in the pathogenesis of periodontitis has not been fully elucidated to date, a number of authors have reported the presence of yeasts in periodontal pockets of subjects with chronic periodontitis, including both immunocompetent and immunocompromised patients18,19.

There are reports in the literature of Candida dubliniensis isolates from non-HIV patients20-22. Ursua B. et al. found that C. albicans and C. dubliniensis were capable of colonizing periodontal pockets, regardless of pocket depth, in non-HIV patients with chronic periodontitis23.

According to Vieira Colombo AP et al., subgingival biofilm can be a source of development and dissemination of systemic infections24. Periodontal scaling could cause fungemia, which in turn could lead to serious complications, depending on the immunological status of the patient.

In the present study, a larger number of Candida dubliniensis strains were isolated from HIV+ patients receiving HAART (Fig. 1), suggesting that compliance with treatment would result in homeostasis between the immunological status of the patient and the yeasts, decreasing the development of opportunistic infections, particularly candidiasis. Vilela MM et al. showed that Candida dubliniensis is less virulent than Candida albicans25.

Paula SB et al. recovered fewer Candida dubliniensis isolates from HIV+ patients receiving HAART26.

The detection of Candida species in periodontal pockets may be due to the ability of these yeasts to adapt to changes in the environment by altering pH, oxygen concentration, and nutrient availability27. This enables them to coexist in the subgingival biofilm and coaggregate with periodontopathic bacteria, as shown in a paper recently published by our research team28.

According to Lourenqo et al, the discrepancies among studies regarding the prevalence of Candida spp. could be due to the method used to collect the study samples, such as swabbing, collecting total saliva or oral rinses.29 In line with Samaranayake et al, the authors found that the oral rinse technique was the most sensitive for detecting Candida spp.30 We consider that collecting subgingival biofilm samples is an adequate method to recover Candida spp.Jewtuchowicz et al. isolated Candida spp. from subgingival samples obtained using a curette from immunocompromised patients22.

Several authors have reported coinfection by Candida dubliniensis and other Candida species, particularly Candida albicans.31 In the present study, we observed coinfection of a single site by both species in two cases: one patient under HAART and the other patient not receiving HAART.

All the strains were identified using phenotypic methods, and then confirmed using molecular biology techniques. Pineda G. et al. suggested that the combined use of at least three phenotypic differentiation techniques might be a valid alternative for laboratories that do not have access to molecular diagnostic methods6.

The transition of yeasts from commensal to opportunistic pathogens is the result of a number of mechanisms to overcome the host's defense barriers, including adhesion, biofilm formation and production of hydrolytic extracellular enzymes such as phospholipase and proteinase; all these properties are considered virulence determinants.

Aspartic proteases play an important role in the degradation of the mucosal (collagen, keratin, and mucin) as well as the immune components (cytokines, antibodies, and complement), facilitating invasion of the host's tissues8.

Phospholipase can damage the host's cell membrane by degrading its constitutive lipids. Phospholipase production can therefore be an important factor in determining the ability of Candida spp. to invade tissues10.

Hemolysin production was observed in all the strains isolated in the present study. Manns et al.showed that iron is found intracellularly as ferritin or contained in the heme group, and that small amounts of extracellular iron are found bound to transport proteins such as transferrin and lactoferrin. Microorganisms also require iron to grow, and their ability to acquire iron is essential to their survival and to establishment of infection9. We understand that hemolysin production is a survival rather than a virulence factor.

The results of the present study showed that both species isolated from patients not receiving HAART produced proteinase (Fig. 2), whereas strains recovered from patients under HAART were low proteinase producers. As suggested by Thomas et al.32 and Ribeiro et al33, this difference could be explained by the use of protease inhibitors in HAART. Nevertheless, other authors posit that the presence of protease inhibitors in HAART does not affect the production of this enzyme34-36.

In the present study, phospholipase production was observed in all the Candida albicans strains isolated from patients not receiving HAART, but in none of the Candida dubliniensis strains from either group of patients. Our findings are in line with studies testing different quantities of Candida dubliniensis strains20,3,21.

CONCLUSIONS

A larger proportion of Candida dubliniensis strains were isolated from the subgingival biofilm of patients receiving HAART, and these strains had fewer virulence factors.

REFERENCES

1 Sardi JC, Duque C, Höfling JF, Gonçalves RB. Genetic and phenotypic evaluation of Candida albicans strains isolated from subgingival biofilm of diabetic patients with chronic periodontitis. Med Mycol. 2012;50:467-475. [ Links ]

2 Quindós G. Epidemiology of invasive mycoses: A landscape in continuous change. Rev Iberoam Micol. 2018;35:171–178. [ Links ]

3 Balero de Paula S, Tadachi Morey A, Pereira Santos J, dos Santos P, et al. Oral Candida colonization in HIV-infected patients in Londrina-PR, Brazil: antifungal susceptibility and virulence factors. J Infect Dev Ctries. 2015;9:1350- 1359. [ Links ]

4 Sullivan D, Coleman D. Candida dubliniensis: Characteristics and Identification. J Clin Microbiol. 1998;36:329-334. [ Links ]

5 López C, Giro L, Ramos L, Ramadán S, Bulacio L. Comparación de diferentes métodos para la identificación de especies del género Candida. Rev Argent Microbiol. 2005;37:16-21. [ Links ]

6 Pineda G, Scollo K, Santiso G, Lehmann E, Arechavala A. Aislamiento de Candida dubliniensis en distintos materiales clínicos. Análisis de métodos fenotípicos de diferenciación con Candida albicans. Rev Arg de Microbiol. 2008;40:211-217. [ Links ]

7 Odds F, Bernaerts R. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J Clin Microbiol. 1994;1924-1929. [ Links ]

8 Ombrella A, Racca L, Ramos L. Actividades proteinasa y fosfolipasa de aislamientos de Candida albicans provenientes de secreciones vaginales con distintos valores de pH. Rev Iberoam Micol. 2008;25:12-16. [ Links ]

9 Manns J, Mosser D, Buckley H. Production of a Hemolytic factor by Candida albicans. Infect. Immun. 1994;5154- 5156. [ Links ]

10 Echeverría A, Durante GA, Arechavala A, Negroni R. Estudio comparativo de dos medios de cultivo para la detección de la actividad de fosfolipasa en cepas de Candida albicans y Cryptococcus neoformans. Rev Iberoam Micol. 2002;19:95-98. [ Links ]

11 Nota Técnica: medios de cultivo caseros para la identificación de hongos de interés médico. Rev Arg Micol. 1994;17:26-33. [ Links ]

12 Gales AC, Pfaller MA, Houston AK, Joly S, Sullivan DJ, Coleman DC, Soll DR. Identification of Candida dubliniensis Based on Temperature and Utilization of Xylose and a-Methyl-D-Glucoside as Determined with the API 20C AUX and Vitek YBC Systems. J Clin Microbiol. 1999;37:3804–3808. [ Links ]

13 Staib P, Morschhäuser J. Chlamydospore formation in Candida albicans and Candida dubliniensis- an enigmatic developmental programme. Mycoses. 2006;50:1-12. [ Links ]

14 Asadzadeh M, Ahmad S, Al-Sweih N, Ziauddin K. Rapid and Accurate Identification of Candida albicans and Candida dubliniensis by Real-Time PCR and Melting Curve Analysis. Med Princ Pract. 2019;27:543–548. [ Links ]

15 Linares C, Loreto E, Silveira C, Pozzatti P, Scheid L, Santuario J, Alves S. Enzymatic and hemolytic activities of Candida dubliniensis strains. Rev Inst Med Trop Sao Paulo. 2007;49:203-206. [ Links ]

16 Price M, Wilkinson I, Gentry L. Plate method for detention of phospholipase activity in Candida albicans. Sabouraudia. 1982;20:7-14. [ Links ]

17 Marcos-Arias C, Eraso E, Madariaga L, Aguirre JM, Quindós G. Phospholipase and Proteinase activities of Candida isolates from dentures wearers. Mycoses. 2019;54:10-16. [ Links ]

18 Barros LM, Boriollo MF, Alves AC, Klein MI, Gonçalves RB, Höfling JF. Genetic diversity and exoenzyme activities of Candida albicans and Candida dubliniensis isolated from the oral cavity of Brazilian periodontal patients. Arch Oral Biol. 2008;53:1172-1178. [ Links ]

19 De-La-Torre J, Quindós G, Marcos-Arias C, Marichalar- Mendia X, et al Oral Candida colonization in patients with chronic periodontitis. Is there any relationship? Rev Iberoam Micol. 2018;35:134-139. [ Links ]

20 Fotedar R, Al-Hedaithy SS. Comparison of phospholipase and proteinase activity in Candida albicans and C. dubliniensis. Mycoses. 2005;48:62-67. [ Links ]

21 Hannula J, Saarela M, Dogan B, Paatsama J, et al. Comparison of virulence factors of oral Candida dubliniensis and Candida albicans isolates in healthy people and patients with chronic candidosis. Oral Microbiol Immunol. 2000;15:238-244. [ Links ]

22 Jewtuchowicz VM1, Mujica MT, Brusca MI, Sordelli N, Malzone MC, Pola SJ, Iovannitti CA, Rosa AC. Phenotypic and genotypic identification of Candida dubliniensis from subgingival sites in immunocompetent subjects in Argentina. Oral Microbiol Immunol. 2008;23:505-509. [ Links ]

23 Urzúa B, Hermosilla G, Gamonal J, Morales-Bozo I, Canals M, Barahona S, Cóccola C, Cifuentes V. Yeast diversity in the oral microbiota of subjects with periodontitis: Candida albicans and Candida dubliniensis colonize the periodontal pockets. Med Mycol. 2008;46:783-793. [ Links ]

24 Vieira Colombo AP, Magalhães CB, Hartenbach FA, Martins do Souto R, Maciel da Silva-Boghossian C. Periodontaldisease- associated biofilm: A reservoir for pathogens of medical importance. Microb Pathog. 2016;94:27-34. [ Links ]

25 Vilela MM, Kamei K, Sano A, Tanaka R, et al. Pathogenicity and virulence of Candida dubliniensis: comparison with C. albicans. Med Mycol. 2002;40:249-257. [ Links ]

26 Paula SB, Morey AT, Santos JP, Santos PM, et al. Oral Candida colonization in HIV-infected patients in Londrina- PR, Brazil: antifungal susceptibility and virulence factors. J Infect Dev Ctries. 2015;9:1350-1359. [ Links ]

27 Sardi JC, Duque C, Mariano FS, Peixoto IT, Höfling JF, Gonçalves RB. Candida spp. in periodontal disease: a brief review. J Oral Sci. 2010;52:177-185. [ Links ]

28 Gliosca LA, D´Eramo L, Bozza F, Soken L, Abusamra L, Salgado P, Squassi A, Molgatini S. Microbiological study of the subgingival biofilm in HIV+/HAART patients at a specialized dental service. Acta Odontol Latinoam. 2019;32:147-155. [ Links ]

29 Lourenço AG, Ribeiro AERA, Nakao C, Motta ACF, Antonio LGL, Machado AA, Komesu MC. Oral Candida spp carriage and periodontal diseases in HIV-infected patients in Ribeirão Preto, Brazil. Rev Inst Med Trop Sao Paulo. 2017;59: e29. doi:10.1590/S1678-9946201759029. [ Links ]

30 Samaranayake LP, MacFarlane TW, Lamey PJ, Ferguson MM. A comparison of oral rinse and imprint sampling techniques for the detection of yeast, coliform and Staphylococcus aureus carriage in the oral cavity. J Oral Pathol. 1986;15:386-388. [ Links ]

31 Jabra-Rizk MA, Ferreira SMS, Sabet M, Falkler WA, Merz WG, Meiller TF. Recovery of Candida dubliniensis and Other Yeasts from Human Immunodeficiency Virus- Associated Periodontal Lesions. J Clin Microbiol. 2001;39:4520-4522. [ Links ]

32 Thomas S, Tsang CSP, Mathew A, Bhaskar S, Priya SP, Varughaes N. A Study on Exoenzyme Activities of Candida albicans Isolated from Oral Cavities of HIV-Infected Patients on HAART. J Hum Virol Retrovirol. 2015;2:00037. doi:10.15406/jhvrv.2015.02.00037. [ Links ]

33 Ribeiro MA, Miranda AE, Gambale W, Paula CR. Prevalence and exoenzyme secretion by Candida albicans isolates from oral and vaginal mucosas of HIV-infected women. Mycopathologia. 2004;157:255–261. [ Links ]

34 Back-Brito GN, El Achkar VNR, Garbim AL, Romeiro RL, Jorge AOC, Balducci I, Koga-Ito CY. HAART therapy does not reduce the proteinase and phospholipase secretion by oral Candida albicans isolated from HIV-positive patients. Rev Inst Adolfo Lutz. 2011;70:101-105. [ Links ]

35 Zanni PCMD, Bonfim-Mendonça PS, Negri M, Nakamura SS, Donatti L, Svidzinski TIE, Consolaro ME. Virulence factors and genetic variability of vaginal Candida albicans isolates from HIV-infected women in the post-highly active antiretroviral era. Rev Inst Med Trop Sao Paulo. 2017;59:e44. doi:10.1590/S1678-9946201759044. [ Links ]

36 de Paula Menezes R, de Melo Riceto ÉB, Borges AS, de Brito Röder DV, dos Santos Pedroso R. Evaluation of virulence factors of Candida albicans isolated from HIVpositive individuals using HAART. Arch Oral Biol. 2016;66:61-65. [ Links ]

FUNDING: The present study was supported by a Grant from University of Buenos Aires, UBACyT Program, code 20720160100002BA.

Received: March 1, 2020; Accepted: September 1, 2020

CORRESPONDENCE Dr. Susana L. Molgatini: Cátedra de Microbiología, Facultad de Odontología, UBA, M.T. de Alvear 2142, Buenos aires, Argentina smolgatini@yahoo.com.ar

Creative Commons License This is an article published in open access under a Creative Commons license